These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 31302952

  • 1. Protocolized hemostatic factor use in major thoracic aortic surgery.
    Wagner MA, Wang H, Benrashid E, Keenan JE, Krishnamurthy Y, Levy JH, Welsby IJ, Hughes GC.
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):633-636. PubMed ID: 31302952
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
    Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
    [Abstract] [Full Text] [Related]

  • 5. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
    Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Ikonomidis JS.
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
    [Abstract] [Full Text] [Related]

  • 6. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J.
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [Abstract] [Full Text] [Related]

  • 7. [Use of activated recombinant factor VII in patients with brain injury or undergoing brain surgery].
    Ingelmo Ingelmo I, Rama-Maceiras P, Fàbregas Julià N, Hernández Palazón J.
    Rev Esp Anestesiol Reanim; 2009 Jun; 56(6):339-42. PubMed ID: 19725340
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
    Al-Ruzzeh S, Ibrahim K, Navia JL.
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
    Johnson SJ, Ross MB, Moores KG.
    Am J Health Syst Pharm; 2007 Sep 01; 64(17):1808-12. PubMed ID: 17724361
    [Abstract] [Full Text] [Related]

  • 12. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
    Khan AZ, Parry JM, Crowley WF, McAllen K, Davis AT, Bonnell BW, Hoogeboom JE.
    Am J Surg; 2005 Mar 01; 189(3):331-4. PubMed ID: 15792762
    [Abstract] [Full Text] [Related]

  • 13. The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
    Tarzia V, Buratto E, Bortolussi G, Paolini C, Bejko J, Bottio T, Gerosa G.
    Artif Organs; 2015 Mar 01; 39(3):248-53. PubMed ID: 25065398
    [Abstract] [Full Text] [Related]

  • 14. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
    Chapman AJ, Blount AL, Davis AT, Hooker RL.
    Eur J Cardiothorac Surg; 2011 Dec 01; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pediatric off-label use of recombinant factor VIIa.
    Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.
    Pediatrics; 2009 Mar 01; 123(3):1066-72. PubMed ID: 19255041
    [Abstract] [Full Text] [Related]

  • 19. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
    van de Garde EM, Bras LJ, Heijmen RH, Knibbe CA, van Dongen EP, Wiltink EH, Biesma DH.
    J Cardiothorac Vasc Anesth; 2006 Aug 01; 20(4):573-5. PubMed ID: 16884993
    [No Abstract] [Full Text] [Related]

  • 20. Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome?
    Saeed G, Ganster G, Friedel N.
    Tex Heart Inst J; 2008 Aug 01; 35(3):373-4; author reply 374-6. PubMed ID: 18941643
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.